Bacterial vaginosis and risk for trichomonas vaginalis infection: A longitudinal analysis

Sexually Transmitted Diseases

Volumn 38, Issue 9, 2011, Pages 882-886

  Rathod, Sujit D ^a   Krupp, Karl ^b   Klausner, Jeffrey D ^c   Arun, Anjali ^b   Reingold, Arthur L ^a   Madhivanan, Purnima ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Public Health Research Institute of India   (India)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; INCIDENCE; INDIA; INFECTION RISK; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PREVALENCE; TRICHOMONIASIS; VAGINA FLORA; VAGINITIS;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INDIA; LONGITUDINAL STUDIES; METRONIDAZOLE; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; VAGINA; VAGINAL SMEARS; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 80051788529     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31821f91a1     Document Type: Article

References (49)

1. Atashili J, Poole C, Ndumbe P, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (London, England) 2008;22:1493.
2. Feigin R. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA: Saunders; 2004.
3. Mitchell H. Vaginal discharge-causes, diagnosis, and treatment. BMJ 2004;328:1306.
4. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev 2004;17:794-803. (Pubitemid 39372518)
5. Paige M, David M, Augustyn M, et al. Bacterial vaginosis and preterm birth: a comprehensive review of the literature. J Nurse Midwifery 1998;43:83-89. (Pubitemid 128724913)
6. Ness R, Kip K, Hillier S, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 2005;162:585.
7. Cherpes TL, Wiesenfeld HC, Melan MA, et al. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis 2006;33:747-752. Doi: 10.1097/01.olq.0000218869.52753.c7. (Pubitemid 44832936)
8. Grodstein F, Goldman M, Cramer D. Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol 1993;137:577.
9. Pellati D, Mylonakis I, Bertoloni G, et al. Genital tract infections and infertility. Eur J Obstet Gynecol Reprod Biol 2008;140:3-11.
10. McClelland R, Sangaré L, Hassan W, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007;195:698.
11. Nagot N, Ouedraogo A, Defer M, et al. Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sex Transm Infect 2007;83:365.
12. Madhivanan P, Bartman MT, Pasutti L, et al. Prevalence of Trichomonas vaginalis infection among young reproductive age women in India: implications for treatment and prevention. Sex Health 2009;6:339-344.
13. Brotman R, Erbelding E, Jamshidi R, et al. Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics. J Pediatr Adolesc Gynecol 2007;20:225-231. (Pubitemid 47126329)
14. Moodley P, Connolly C, Sturm A. Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J Infect Dis 2002;185:69-73. (Pubitemid 34043018)
15. Demirezen S, Korkmaz E, Beksac M. Association between trichomoniasis and bacterial vaginosis: examination of 600 cervicovaginal smears. Cent Eur J Public Health 2005;13:96-98. (Pubitemid 40825400)
16. Kaul R, Nagelkerke N, Kimani J, et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis 2007;196:1692-1697. (Pubitemid 351411969)
17. Gatski M, Martin DH, Clark RA, et al. Co-Occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis 2011;38:163-166.
18. Josey W, Schwebke J. The polymicrobial hypothesis of bacterial vaginosis causation: a reassessment. Int J STD AIDS 2008;19:152.
19. Schwebke J. Bacterial vaginosis. Curr Infect Dis Rep 2000;2:14-17.
20. Martin H Jr, Richardson B, Nyange P, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863-1868.
21. Livengood C III. Bacterial vaginosis: an overview for 2009. Rev Obstet Gynecol 2009;2:28.
22. Brotman R, Klebanoff M, Nansel T, et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis 2010;202:1907.
23. Krupp K, Madhivanan P, Karat C, et al. Novel recruitment strategies to increase participation of women in reproductive health research in India. Glob Public Health 2007;2:395-403. (Pubitemid 350253541)
24. Madhivanan P, Krupp K, Chandrasekaran V, et al. Prevalence and correlates of bacterial vaginosis among young women of reproductive age in Mysore, India. Indian J Med Microbiol 2008;26:132.
25. Madhivanan P, Krupp K, Chandrasekaran V, et al. The epidemiology of herpes simplex virus type-2 infection among married women in Mysore, India. Sex Transm Dis 2007;34:935.
26. Amsel R, Totten P, Spiegel C, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22. (Pubitemid 13221599)
27. Nugent R, Krohn M, Hillier S. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297.
28. Hubbard AE, Ahern J, Fleischer NL, et al. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology 2010;21:467.
29. Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan 2006;21:459.
30. Cohen C, Duerr A, Pruithithada N, et al. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995;9:1093.
31. Sewankambo N, Gray R, Wawer M, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546-550. (Pubitemid 27348430)
32. Taha T, Gray R, Kumwenda N, et al. HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syndr 1999;20:52.
33. Hillier S, Krohn M, Klebanoff S, Eschenbach D. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol 1992;79:369.
34. Thurman A, Doncel G. Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition. Am J Reprod Immunol (New York, NY: 1989) 2011;65:89-98.
35. Alderete JF, Garza GE. Specific nature of Trichomonas vaginalis parasitism of host cell surfaces. Infect Immun 1985;50:701.
36. Diamond LS. In vitro cultivation of the Trichomonadidae: a state of the art review. Acta Univ Carol-Biol 1986;30:221-228.
37. Kostara I, Carageorgiou H, Varonos D, et al. Growth and survival of Trichomonas vaginalis. J Med Microbiol 1998;47:555.
38. Rein M, Chapel T. Trichomoniasis, candidiasis, and the minor venereal diseases. Clinical Obstet Gynecol 1975;18:73.
39. Mitchell C, Hitti J, Agnew K, et al. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria. BMC Infect Dis 2009;9:89.
40. Lossick J. Single-dose metronidazole treatment for vaginal trichomoniasis. Obstet Gynecol 1980;56:508.
41. Bowden F, Garnett G. Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions. Sex Transm Infect 2000;76:248.
42. Schmid G, Steen R, N'Dowa F. Control of bacterial sexually transmitted diseases in the developing world is possible. Clin Infect Dis 2005;41:1313-1315. (Pubitemid 41532675)
43. Gray P. HIV and Islam: is HIV prevalence lower among Muslims? Soc Sci Med 2004;58:1751-1756. (Pubitemid 38281140)
44. Weiss H, Thomas S, Munabi S, Hayes R. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. BMJ 2006;82:101.
45. Klinger E, Kapiga S, Sam N, et al. A community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania. Sex Transm Dis 2006;33:712.
46. Brown J, Wald A, Hubbard A, et al. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS 2007;21:1515.
47. Centers for Disease Control. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 Years: United States, 2005-2008. MMWR 2010;59:456-459.
48. Brotman R, Ravel J, Cone R, et al. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect 2010;86:297.
49. Gulmezoglu A, Garner P. Trichomoniasis treatment in women: a systematic review. Trop Med Int Health 1998;3:553-558. (Pubitemid 28373864)